Catastrophic transverse myelitis in a patient with systemic lupus erythematosus

Modern Rheumatology

Volumn 15, Issue 2, 2005, Pages 130-133

  Yamanaka, Futoshi ^a   Migita, Kiyoshi ^a   Ichinose, Katsuhiro ^a   Ohno, Naoyoshi ^a   Kimura, Hironori ^a   Ishimaru, Hideki ^a   Matsuoka, Yojiro ^a   Eguchi, Katsumi ^b   Ezaki, Hironori ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Intravenous cyclophosphamide (IV CY); Systemic lupus erythematosus (SLE); Transverse myelitis (TM)

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE;

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; CERVICAL SPINE; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FEVER; HEMATURIA; HOSPITAL ADMISSION; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; LEG MUSCLE; LUMBAR SPINE; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; PATIENT TRANSPORT; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; SIGNAL DETECTION; SPINAL CORD; SYSTEMIC LUPUS ERYTHEMATOSUS; THORACIC SPINE;

EID: 20444484152     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0376-4     Document Type: Article

References (13)

1. Warren RW, Kredich DW. Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1984;27:1058-60.
2. Mok CC, Lau CS, Chan EY, Wong RW. Acute transverse myelopathy in systemic lupus erythematosus: Clinical presentation, treatment, and outcome. J Rheumatol 1998;25:467-73.
3. Barile L, Lavalle C. Transverse myelitis in systemic lupus erythematosus - the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 1992;19:370-2.
4. Kovacs B, Lafferty TL, Brent LH, De Horatius RJ. Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-4.
5. al-Mayouf SM, Bahabri S. Spinal cord involvement in pediatric systemic lupus erythematosus: Case report and literature review. Clin Exp Rheumatol 1999;17:505-8.
6. Provenzale J, Bouldin TW. Lupus-related myelopathy: Report of three cases and review of the literature. J Neurol Neurosurg Psychiatry 1992;55:830-5.
7. Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis. J Rheumatol 1999;26:446-9.
8. Habr F, Wu B. Acute transverse myelitis in systemic lupus erythematosus: a case of rapid diagnosis and complete recovery. Conn Med 1998;62:387-90.
9. Krauss WE. Vascular anatomy of the spinal cord. Neurosurg Clin North Am 1999;10:9-15.
10. Kimura KY, Seino Y, Hirayama Y, Aramaki T, Yamaguchi H, Amano H, et al. Systemic lupus erythematosus related transverse myelitis presenting longitudinal involvement of the spinal cord. Intern Med 2002;41:156-60.
11. Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Transverse myelitis: A manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990;17:34-7.
12. D'Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: Good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 2004;31:280-5.
13. Saito K, Nawata M, Nakayamada S, Tokunaga M, Tsukada J, Tanaka Y. Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement. Lupos 2003;12:798-800.